+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Immunohematology Market 2023-2027

  • PDF Icon

    Report

  • 160 Pages
  • July 2023
  • Region: Global
  • TechNavio
  • ID: 5232248
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunohematology market is forecasted to grow by USD 1,277.05 mn during 2022-2027, accelerating at a CAGR of 9.06% during the forecast period. The report on the immunohematology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by shift by end-users to automated immunohematology analyzers, growing demand for blood banks and their potential to increase sales, and increasing sales through service-oriented sales organizations and GPOS.

The immunohematology market is segmented as below:

By Product

  • Analyzers and systems
  • Reagents

By End-user

  • Hospitals
  • Blood banks
  • Diagnostic laboratories

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the paradigm shift toward molecular immunohematology as one of the prime reasons driving the immunohematology market growth during the next few years. Also, public and private partnerships to establish blood banks and increase in adoption of next-generation hematology diagnostic products will lead to sizable demand in the market.

The report on the immunohematology market covers the following areas:

  • Immunohematology market sizing
  • Immunohematology market forecast
  • Immunohematology market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunohematology market vendors that include Becton Dickinson and Co., Biomed Global, Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Institut de Biotechnologies Jacques Boy, MAK SYSTEM S.A., Merck KGaA, Mesa Laboratories Inc., Quotient Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tulip Diagnostics Pvt. Ltd., Werfenlife SA, and Calibre Scientific Inc.. Also, the immunohematology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global immunohematology market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global immunohematology market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Analyzers and systems - Market size and forecast 2022-2027
Exhibit 34: Chart on Analyzers and systems - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Analyzers and systems - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Analyzers and systems - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Analyzers and systems - Year-over-year growth 2022-2027 (%)
6.4 Reagents - Market size and forecast 2022-2027
Exhibit 38: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Reagents - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Blood banks - Market size and forecast 2022-2027
Exhibit 52: Chart on Blood banks - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Blood banks - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Blood banks - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Blood banks - Year-over-year growth 2022-2027 (%)
7.5 Diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 56: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Becton Dickinson and Co.
Exhibit 111: Becton Dickinson and Co. - Overview
Exhibit 112: Becton Dickinson and Co. - Business segments
Exhibit 113: Becton Dickinson and Co. - Key news
Exhibit 114: Becton Dickinson and Co. - Key offerings
Exhibit 115: Becton Dickinson and Co. - Segment focus
12.4 Bio Rad Laboratories Inc.
Exhibit 116: Bio Rad Laboratories Inc. - Overview
Exhibit 117: Bio Rad Laboratories Inc. - Business segments
Exhibit 118: Bio Rad Laboratories Inc. - Key news
Exhibit 119: Bio Rad Laboratories Inc. - Key offerings
Exhibit 120: Bio Rad Laboratories Inc. - Segment focus
12.5 biosurfit SA
Exhibit 121: biosurfit SA - Overview
Exhibit 122: biosurfit SA - Product/Service
Exhibit 123: biosurfit SA - Key offerings
12.6 Cardinal Health Inc.
Exhibit 124: Cardinal Health Inc. - Overview
Exhibit 125: Cardinal Health Inc. - Business segments
Exhibit 126: Cardinal Health Inc. - Key news
Exhibit 127: Cardinal Health Inc. - Key offerings
Exhibit 128: Cardinal Health Inc. - Segment focus
12.7 Danaher Corp.
Exhibit 129: Danaher Corp. - Overview
Exhibit 130: Danaher Corp. - Business segments
Exhibit 131: Danaher Corp. - Key news
Exhibit 132: Danaher Corp. - Key offerings
Exhibit 133: Danaher Corp. - Segment focus
12.8 DIAGAST SAS
Exhibit 134: DIAGAST SAS - Overview
Exhibit 135: DIAGAST SAS - Product/Service
Exhibit 136: DIAGAST SAS - Key offerings
12.9 Grifols SA
Exhibit 137: Grifols SA - Overview
Exhibit 138: Grifols SA - Business segments
Exhibit 139: Grifols SA - Key offerings
Exhibit 140: Grifols SA - Segment focus
12.10 Hemo bioscience Inc.
Exhibit 141: Hemo bioscience Inc. - Overview
Exhibit 142: Hemo bioscience Inc. - Product/Service
Exhibit 143: Hemo bioscience Inc. - Key offerings
12.11 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
Exhibit 144: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibit 145: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product/Service
Exhibit 146: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
12.12 Institut de Biotechnologies Jacques Boy
Exhibit 147: Institut de Biotechnologies Jacques Boy - Overview
Exhibit 148: Institut de Biotechnologies Jacques Boy - Product/Service
Exhibit 149: Institut de Biotechnologies Jacques Boy - Key offerings
12.13 MAK SYSTEM S.A.
Exhibit 150: MAK SYSTEM S.A. - Overview
Exhibit 151: MAK SYSTEM S.A. - Product/Service
Exhibit 152: MAK SYSTEM S.A. - Key offerings
12.14 Merck KGaA
Exhibit 153: Merck KGaA - Overview
Exhibit 154: Merck KGaA - Business segments
Exhibit 155: Merck KGaA - Key news
Exhibit 156: Merck KGaA - Key offerings
Exhibit 157: Merck KGaA - Segment focus
12.15 Mesa Laboratories Inc.
Exhibit 158: Mesa Laboratories Inc. - Overview
Exhibit 159: Mesa Laboratories Inc. - Business segments
Exhibit 160: Mesa Laboratories Inc. - Key offerings
Exhibit 161: Mesa Laboratories Inc. - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 162: Thermo Fisher Scientific Inc. - Overview
Exhibit 163: Thermo Fisher Scientific Inc. - Business segments
Exhibit 164: Thermo Fisher Scientific Inc. - Key news
Exhibit 165: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 166: Thermo Fisher Scientific Inc. - Segment focus
12.17 Werfenlife SA
Exhibit 167: Werfenlife SA - Overview
Exhibit 168: Werfenlife SA - Product/Service
Exhibit 169: Werfenlife SA - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global immunohematology market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Analyzers and systems - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Analyzers and systems - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Analyzers and systems - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Analyzers and systems - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Reagents - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Product ($ million)
Exhibits 43: Data Table on Market opportunity by Product ($ million)
Exhibits 44: Chart on End-user - Market share 2022-2027 (%)
Exhibits 45: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by End-user
Exhibits 47: Data Table on Comparison by End-user
Exhibits 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Blood banks - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Blood banks - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Blood banks - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Blood banks - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 60: Market opportunity by End-user ($ million)
Exhibits 61: Data Table on Market opportunity by End-user ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2022 and 2027
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Becton Dickinson and Co. - Overview
Exhibits 112: Becton Dickinson and Co. - Business segments
Exhibits 113: Becton Dickinson and Co. - Key news
Exhibits 114: Becton Dickinson and Co. - Key offerings
Exhibits 115: Becton Dickinson and Co. - Segment focus
Exhibits 116: Bio Rad Laboratories Inc. - Overview
Exhibits 117: Bio Rad Laboratories Inc. - Business segments
Exhibits 118: Bio Rad Laboratories Inc. - Key news
Exhibits 119: Bio Rad Laboratories Inc. - Key offerings
Exhibits 120: Bio Rad Laboratories Inc. - Segment focus
Exhibits 121: biosurfit SA - Overview
Exhibits 122: biosurfit SA - Product/Service
Exhibits 123: biosurfit SA - Key offerings
Exhibits 124: Cardinal Health Inc. - Overview
Exhibits 125: Cardinal Health Inc. - Business segments
Exhibits 126: Cardinal Health Inc. - Key news
Exhibits 127: Cardinal Health Inc. - Key offerings
Exhibits 128: Cardinal Health Inc. - Segment focus
Exhibits 129: Danaher Corp. - Overview
Exhibits 130: Danaher Corp. - Business segments
Exhibits 131: Danaher Corp. - Key news
Exhibits 132: Danaher Corp. - Key offerings
Exhibits 133: Danaher Corp. - Segment focus
Exhibits 134: DIAGAST SAS - Overview
Exhibits 135: DIAGAST SAS - Product/Service
Exhibits 136: DIAGAST SAS - Key offerings
Exhibits 137: Grifols SA - Overview
Exhibits 138: Grifols SA - Business segments
Exhibits 139: Grifols SA - Key offerings
Exhibits 140: Grifols SA - Segment focus
Exhibits 141: Hemo bioscience Inc. - Overview
Exhibits 142: Hemo bioscience Inc. - Product/Service
Exhibits 143: Hemo bioscience Inc. - Key offerings
Exhibits 144: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibits 145: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product/Service
Exhibits 146: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
Exhibits 147: Institut de Biotechnologies Jacques Boy - Overview
Exhibits 148: Institut de Biotechnologies Jacques Boy - Product/Service
Exhibits 149: Institut de Biotechnologies Jacques Boy - Key offerings
Exhibits 150: MAK SYSTEM S.A. - Overview
Exhibits 151: MAK SYSTEM S.A. - Product/Service
Exhibits 152: MAK SYSTEM S.A. - Key offerings
Exhibits 153: Merck KGaA - Overview
Exhibits 154: Merck KGaA - Business segments
Exhibits 155: Merck KGaA - Key news
Exhibits 156: Merck KGaA - Key offerings
Exhibits 157: Merck KGaA - Segment focus
Exhibits 158: Mesa Laboratories Inc. - Overview
Exhibits 159: Mesa Laboratories Inc. - Business segments
Exhibits 160: Mesa Laboratories Inc. - Key offerings
Exhibits 161: Mesa Laboratories Inc. - Segment focus
Exhibits 162: Thermo Fisher Scientific Inc. - Overview
Exhibits 163: Thermo Fisher Scientific Inc. - Business segments
Exhibits 164: Thermo Fisher Scientific Inc. - Key news
Exhibits 165: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 166: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 167: Werfenlife SA - Overview
Exhibits 168: Werfenlife SA - Product/Service
Exhibits 169: Werfenlife SA - Key offerings
Exhibits 170: Inclusions checklist
Exhibits 171: Exclusions checklist
Exhibits 172: Currency conversion rates for US$
Exhibits 173: Research methodology
Exhibits 174: Validation techniques employed for market sizing
Exhibits 175: Information sources
Exhibits 176: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global immunohematology market: Becton Dickinson and Co., Biomed Global, Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Institut de Biotechnologies Jacques Boy, MAK SYSTEM S.A., Merck KGaA, Mesa Laboratories Inc., Quotient Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tulip Diagnostics Pvt. Ltd., Werfenlife SA, and Calibre Scientific Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is paradigm shift toward molecular immunohematology.'

According to the report, one of the major drivers for this market is demand for blood banks and their potential to increase sales.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton Dickinson and Co.
  • Biomed Global
  • Bio Rad Laboratories Inc.
  • biosurfit SA
  • Cardinal Health Inc.
  • Danaher Corp.
  • DIAGAST SAS
  • Grifols SA
  • Hemo bioscience Inc.
  • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
  • Institut de Biotechnologies Jacques Boy
  • MAK SYSTEM S.A.
  • Merck KGaA
  • Mesa Laboratories Inc.
  • Quotient Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics Pvt. Ltd.
  • Werfenlife SA
  • Calibre Scientific Inc.